
Compliance with risk management plan recommendations on laboratory monitoring of antitumor necrosis factor-α therapy in clinical practice
Keywords: هپاتیت ویروسی; antitumor necrosis factor-α; infection; pharmacovigilance; risk management plan; tuberculosis; viral hepatitis